23,036,271
Vote Records
25,695
Companies
11,771
Funds
3,902
Managers

Home › Companies › EDITAS MEDICINE INC. › 2023-2024

EDITAS MEDICINE INC. 2023-2024 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and EDITAS MEDICINE INC.’s Form 8-K, filed May 31, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 5Ballot items
  • 287Asset managers, any item
  • 1,281Fund votes
  • May 30, 2024Meeting date

Results at a glance

Meeting of May 30, 2024: 5 items on EDITAS MEDICINE INC.’s Form 8-K, filed May 31, 2024: 2 approved · 3 passed (calculated).

Dissent

Significant dissent: 3 directors (21.2%, 21.2%, 20.9% against).

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Activist investors: Ra Capital Management, L.P. (13F, 5.8%, as of September 30, 2026)

Explore EDITAS MEDICINE INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by EDITAS MEDICINE INC.

These tallies are EDITAS MEDICINE INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 31, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

EDITAS MEDICINE INC. — official shareholder meeting results, meeting held May 30, 2024
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Meeta Chatterjee, Ph.D. 32,769,825---- 8,815,67817,765,319 79%Passed (calculated)—
Elect Director: Andrew Hirsch 32,759,650---- 8,825,85317,765,319 79%Passed (calculated)—
Elect Director: Gilmore O'Neill, M.B. 32,909,172---- 8,676,33117,765,319 79%Passed (calculated)—
2. The compensation paid to its named executive officers 38,609,8282,769,887205,788 --17,765,319 93%Approved—
3. The selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the current fiscal year 57,952,408362,1171,036,297 --0 99.4%Approved—

Source: EDITAS MEDICINE INC., Form 8-K, filed with the SEC on May 31, 2024 — read the filing on EDGAR.

How asset managers voted at the EDITAS MEDICINE INC. 2023-2024 meeting

287 asset managers disclosed a vote on at least one EDITAS MEDICINE INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.

Elect Director: Andrew Hirsch

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 3 wordings of this item as funds reported it.

79% Majority: yes · of votes cast

FOR 79%WITHHELD
FOR: 32,759,650WITHHELD: 8,825,853
Details: description as filed, official tally, votes by 58 asset managers

Description as filed by funds: Election of three Class II Directors, each to serve until the 2027 Annual Meeting of Stockholders: Andrew Hirsch

EDITAS MEDICINE INC.’s own tally for this item (“Elect Director: Andrew Hirsch”): 32,759,650 for, 8,825,853 withheld, per its Form 8-K filed May 31, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 79% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 58 asset managers below reported 19,301,339 for, 3,544,425 withheld, 83,576 abstained.

FORWITHHOLD
FOR: 19,301,339ABSTAIN: 83,576WITHHOLD: 3,544,425
Largest asset managers voting on “Election of three Class II Directors, each to serve until the 2027 Annual Meeting of Stockholders: Andrew Hirs” at EDITAS MEDICINE INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard8,440,6660 00For
State Street5,754,8470 084,150For
BlackRock1,799,3710 00For
Dimensional00 01,668,990Withhold
TIAA1,003,6720 00For
Charles Schwab856,0950 00For
Direxion Shares ETF Trust00 0633,402Withhold
Goldman Sachs00 0520,168Withhold
Fidelity293,3680 00For
Equitable124,7370 081,300Mixed
Global X185,3980 00For
SEI158,1180 00For
ProShares00 0145,221Withhold
Neuberger Berman137,8260 00For
QUANTITATIVE MASTER SERIES LLC125,4340 00For
American Century00 0111,152Withhold
Jackson National71,0430 20,6350Mixed
Northern Trust79,3370 00For
Victory Capital00 078,471Withhold
Lincoln Financial70,9380 03,993Mixed
Bridge Builder Trust33,5450 23,9600Mixed
AIG/SunAmerica00 040,870Withhold
Pacific Life32,3180 00For
Listed Funds Trust00 031,670Withhold
Prudential/PGIM31,2950 00For

Showing the 25 largest of 58 asset managers. All 58 are in the interactive database (link above).

Elect Director: Gilmore O'Neill, M.B.

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 3 wordings of this item as funds reported it.

79% Majority: yes · of votes cast

FOR 79%WITHHELD
FOR: 32,909,172WITHHELD: 8,676,331
Details: description as filed, official tally, votes by 58 asset managers

Description as filed by funds: Election of three Class II Directors, each to serve until the 2027 Annual Meeting of Stockholders: Gilmore O'Neill, M.B.

EDITAS MEDICINE INC.’s own tally for this item (“Elect Director: Gilmore O'Neill, M.B.”): 32,909,172 for, 8,676,331 withheld, per its Form 8-K filed May 31, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 79% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 58 asset managers below reported 19,382,639 for, 3,463,125 withheld, 83,576 abstained.

FORWITHHOLD
FOR: 19,382,639ABSTAIN: 83,576WITHHOLD: 3,463,125
Largest asset managers voting on “Election of three Class II Directors, each to serve until the 2027 Annual Meeting of Stockholders: Gilmore O'N” at EDITAS MEDICINE INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard8,440,6660 00For
State Street5,754,8470 084,150For
BlackRock1,799,3710 00For
Dimensional00 01,668,990Withhold
TIAA1,003,6720 00For
Charles Schwab856,0950 00For
Direxion Shares ETF Trust00 0633,402Withhold
Goldman Sachs00 0520,168Withhold
Fidelity293,3680 00For
Equitable206,0370 00For
Global X185,3980 00For
SEI158,1180 00For
ProShares00 0145,221Withhold
Neuberger Berman137,8260 00For
QUANTITATIVE MASTER SERIES LLC125,4340 00For
American Century00 0111,152Withhold
Jackson National71,0430 20,6350Mixed
Northern Trust79,3370 00For
Victory Capital00 078,471Withhold
Lincoln Financial70,9380 03,993Mixed
Bridge Builder Trust33,5450 23,9600Mixed
AIG/SunAmerica00 040,870Withhold
Pacific Life32,3180 00For
Listed Funds Trust00 031,670Withhold
Prudential/PGIM31,2950 00For

Showing the 25 largest of 58 asset managers. All 58 are in the interactive database (link above).

Elect Director: Meeta Chatterjee, Ph.D.

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 3 wordings of this item as funds reported it.

79% Majority: yes · of votes cast

FOR 79%WITHHELD
FOR: 32,769,825WITHHELD: 8,815,678
Details: description as filed, official tally, votes by 58 asset managers

Description as filed by funds: Election of three Class II Directors, each to serve until the 2027 Annual Meeting of Stockholders: Meeta Chatterjee, Ph.D.

EDITAS MEDICINE INC.’s own tally for this item (“Elect Director: Meeta Chatterjee, Ph.D.”): 32,769,825 for, 8,815,678 withheld, per its Form 8-K filed May 31, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 79% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 58 asset managers below reported 19,301,339 for, 3,544,425 withheld, 83,576 abstained.

FORWITHHOLD
FOR: 19,301,339ABSTAIN: 83,576WITHHOLD: 3,544,425
Largest asset managers voting on “Election of three Class II Directors, each to serve until the 2027 Annual Meeting of Stockholders: Meeta Chatt” at EDITAS MEDICINE INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard8,440,6660 00For
State Street5,754,8470 084,150For
BlackRock1,799,3710 00For
Dimensional00 01,668,990Withhold
TIAA1,003,6720 00For
Charles Schwab856,0950 00For
Direxion Shares ETF Trust00 0633,402Withhold
Goldman Sachs00 0520,168Withhold
Fidelity293,3680 00For
Equitable124,7370 081,300Mixed
Global X185,3980 00For
SEI158,1180 00For
ProShares00 0145,221Withhold
Neuberger Berman137,8260 00For
QUANTITATIVE MASTER SERIES LLC125,4340 00For
American Century00 0111,152Withhold
Jackson National71,0430 20,6350Mixed
Northern Trust79,3370 00For
Victory Capital00 078,471Withhold
Lincoln Financial70,9380 03,993Mixed
Bridge Builder Trust33,5450 23,9600Mixed
AIG/SunAmerica00 040,870Withhold
Pacific Life32,3180 00For
Listed Funds Trust00 031,670Withhold
Prudential/PGIM31,2950 00For

Showing the 25 largest of 58 asset managers. All 58 are in the interactive database (link above).

The compensation paid to its named executive officers

Official resultFund totals may overlapCOMPENSATIONReported outcome: Approved

Combines 17 wordings of this item as funds reported it.

93% Approved · of votes cast

FOR 93%
FOR: 38,609,828AGAINST: 2,769,887

Prior year: 89.8% for (June 1, 2023 meeting) ▲ 3.5 pts

Details: description as filed, official tally, votes by 286 asset managers

Description as filed by funds: To approve, on an advisory basis, the compensation paid to the Company's named executive officers.

EDITAS MEDICINE INC.’s own tally for this item (“2. The compensation paid to its named executive officers”): 38,609,828 for, 2,769,887 against — passed, per its Form 8-K filed May 31, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved, on an advisory basis, the compensation paid to its named executive officers.”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 60 asset managers voting on “To approve, on an advisory basis, the compensation paid to the Company's named executive officers.” at EDITAS MEDICINE INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard8,440,6660 00For
State Street5,838,9970 00For
BlackRock1,799,3710 00For
Dimensional1,668,9900 00For
TIAA1,003,6720 00For
Charles Schwab856,0950 00For
Direxion Shares ETF Trust633,4020 00For
Goldman Sachs520,1680 00For
Fidelity293,3680 00For
Equitable206,0370 00For
Global X185,3980 00For
SEI158,1180 00For
ProShares145,2210 00For
Neuberger Berman137,8260 00For
QUANTITATIVE MASTER SERIES LLC125,4340 00For
American Century111,1520 00For
Jackson National91,6780 00For
Investment Managers Series Trust II089,803 00Against
Northern Trust79,3370 00For
Victory Capital78,4710 00For
Lincoln Financial74,9310 00For
Bridge Builder Trust57,5050 00For
AIG/SunAmerica40,8700 00For
Pacific Life32,3180 00For
Listed Funds Trust31,6700 00For

Fund voting reports, all 60 managers: 22,902,037 for, 98,048 against, 20,268 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 247 asset managers voting on “To approve, on an advisory basis, the compensation paid to the Company's named executive officers.” at EDITAS MEDICINE INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
State Street7,371,9000 00For
BlackRock2,505,7280 00For
Deep Track Capital, LP1,920,4290 00For
PICTET ASSET MANAGEMENT SA1,126,1510 00For
Nuveen1,013,8800 00For
JPMorgan987,5020 00For
Woodline Partners LP895,0000 00For
Charles Schwab856,0950 00For
UBS3,287700,266 00Against
MARSHALL WACE, LLP0693,855 00Against
Rafferty Asset Management, LLC633,4020 00For
DE Shaw476,8050 00For
Northern Trust428,9402,878 00For
GEODE CAPITAL MANAGEMENT, LLC343,7630 00For
Dimensional306,8710 00For
Neuberger Berman275,4520 00For
STIFEL NICOLAUS & CO INC \MO\247,1210 00For
Two Sigma204,2330 00For
PARAMETRIC PORTFOLIO ASSOCIATES LLC162,3410 00For
SEI161,8920 00For
Goldman Sachs153,1650 00For
MELLON INVESTMENTS Corp151,9120 00For
Knott David M Jr140,0000 00For
Citadel130,5230 00For
Connor, Clark & Lunn Investment Management Ltd.119,5600 00For

Institutional-manager reports, all 247 managers: 22,251,338 for, 1,592,540 against, 270 abstained, 19,771 not voted. Showing the 25 largest; every one is in the interactive database (link above).

The selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the current…

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 3 wordings of this item as funds reported it.

99.4% Approved · of votes cast

FOR 99.4%
FOR: 57,952,408AGAINST: 362,117

Prior year: 99.2% for (June 1, 2023 meeting) ▲ 0.2 pts

Details: description as filed, official tally, votes by 61 asset managers

Description as filed by funds: TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2024.

EDITAS MEDICINE INC.’s own tally for this item (“3. The selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the current fiscal year”): 57,952,408 for, 362,117 against — passed, per its Form 8-K filed May 31, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The Company's stockholders ratified the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the current fiscal year.”
Support: 99.4% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 61 asset managers below reported 22,990,189 for, 9,916 against, 20,268 abstained.

FOR
FOR: 22,990,189AGAINST: 9,916ABSTAIN: 20,268
Largest asset managers voting on “TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ” at EDITAS MEDICINE INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard8,440,6660 00For
State Street5,829,0819,916 00For
BlackRock1,799,3710 00For
Dimensional1,668,9900 00For
TIAA1,003,6720 00For
Charles Schwab856,0950 00For
Direxion Shares ETF Trust633,4020 00For
Goldman Sachs520,1680 00For
Fidelity293,3680 00For
Equitable206,0370 00For
Global X185,3980 00For
SEI158,1180 00For
ProShares145,2210 00For
Neuberger Berman137,8260 00For
QUANTITATIVE MASTER SERIES LLC125,4340 00For
American Century111,1520 00For
Jackson National91,6780 00For
Investment Managers Series Trust II89,8030 00For
Northern Trust79,3370 00For
Victory Capital78,4710 00For
Lincoln Financial74,9310 00For
Bridge Builder Trust57,5050 00For
AIG/SunAmerica40,8700 00For
Pacific Life32,3180 00For
Listed Funds Trust31,6700 00For

Showing the 25 largest of 61 asset managers. All 61 are in the interactive database (link above).

Largest EDITAS MEDICINE INC. shareholders voting in 2023-2024

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 82,234,951 shares outstanding at the time of that meeting.

Fund voting reports: top EDITAS MEDICINE INC. shareholders by shares voted on “To approve, on an advisory basis, the compensation paid to the Company's named executive…”, 2023-2024
#Asset manager % of shares outstanding
1Vanguard 10.26%
2State Street 7.10%
3BlackRock 2.19%
4Dimensional 2.03%
5TIAA 1.22%
6Charles Schwab 1.04%
7Direxion Shares ETF Trust 0.77%
8Goldman Sachs 0.63%
9Fidelity 0.36%
10Equitable 0.25%
Institutional-manager reports: top EDITAS MEDICINE INC. shareholders by shares voted on “To approve, on an advisory basis, the compensation paid to the Company's named executive…”, 2023-2024
#Asset manager % of shares outstanding
1State Street 8.96%
2BlackRock 3.05%
3Deep Track Capital, LP 2.34%
4PICTET ASSET MANAGEMENT SA 1.37%
5Nuveen 1.23%
6JPMorgan 1.20%
7Woodline Partners LP 1.09%
8Charles Schwab 1.06%
9UBS 0.86%
10MARSHALL WACE, LLP 0.84%

Reported EDITAS MEDICINE INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

EDITAS MEDICINE INC. holdings and ownership disclosed for the 2023-2024 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
State Street8,760,151 10.65%Form 13F, quarter ended March 31, 2024
BlackRock8,019,891 9.75%Form 13F, quarter ended March 31, 2024
Vanguard Group6,965,618 8.47%Form 13F, quarter ended March 31, 2024
Deep Track Capital, LP5,473,086 6.66%Proxy statement (DEF 14A), proxy filed April 16, 2024
Dimensional Fund Advisors2,607,765 3.17%Form 13F, quarter ended March 31, 2024
Millennium Management2,236,617 2.72%Form 13F, quarter ended March 31, 2024
Geode Capital1,944,763 2.36%Form 13F, quarter ended March 31, 2024
Two Sigma1,387,982 1.69%Form 13F, quarter ended March 31, 2024
D.E. Shaw1,089,240 1.32%Form 13F, quarter ended March 31, 2024
Morgan Stanley1,087,907 1.32%Form 13F, quarter ended March 31, 2024

Percentages above are of 82,234,951 shares outstanding, as reported by EDITAS MEDICINE INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At EDITAS MEDICINE INC.'s shareholder meeting held May 30, 2024, in the 2023-2024 proxy season, 287 asset managers reported votes on at least one of its 5 ballot items in their SEC Form N-PX filings, covering 1,281 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation paid to the Company's named executive… — EDITAS MEDICINE INC.'s filing reports the proposal as approved, with 93% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: EDITAS MEDICINE INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 31, 2024.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from EDITAS MEDICINE INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

EDITAS MEDICINE INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.

Cite this page

Proxy Votes Now, “EDITAS MEDICINE (EDIT) 2024 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/editas-medicine-inc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.